Clinical trial · Interventional
Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma
NCT03068637CI-TRIAL-00033327completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overarching objective of this study is to evaluate the feasibility, usability, and acceptability of an abbreviated, tablet-based geriatric assessment in a population of older adults with multiple myeloma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Carevive CPS | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Care planning platform usage
- description
- This intervention will focus on the use of the Carevive care planning software for multiple myeloma patients age 65 and older who are at a treatment decision-making timepoint.
- interventionNames
- Behavioral: Carevive CPS
Primary outcomes (2)
- measure
- Feasibility, usability, and acceptability of a tablet-based modified geriatric assessment using online questionnaires.
- timeFrame
- Years 1-2
- description
- This study will evaluate the feasibility, usability, and acceptability of a tablet-based modified geriatric assessment completed by patients and presented to clinicians at a treatment decision-making visit for older adults with multiple myeloma. Data from multiple qualitative online questionnaires will be aggregated together to arrive at one reported value, utility of a tablet-based modified geriatric assessment.
- measure
- Physician use and perceived utility of the modified geriatric assessment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * 65 years of age or older * Diagnosis of multiple myeloma * Newly diagnoses or needing a new line of therapy and have not yet made a treatment decision * Must be able to understand English Exclusion Criteria: * Any patient who cannot understand written or spoken English * Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C, and D)
References
Publications (0)
Data not yet available
No reference posted for this study.